Coagulation cascade proteins (Heparin-binding)

Coagulation cascade proteins that interact with sulfated polysaccharides constitute a vital network of enzymes and inhibitors regulating blood hemostasis. This target group includes key procoagulant serine proteases such as Thrombin (Factor IIa), Factor Xa, and Factor IXa, alongside their primary endogenous regulator, Antithrombin III (ATIII) [1][2]. Sulfated polysaccharides, including heparin and various heparin-mimetics, bind to these proteins to modulate their activity, most commonly by inducing a conformational change in ATIII that increases its affinity for Thrombin and Factor Xa by several thousand-fold [3][4]. These interactions are fundamental to the pharmacological action of widely used anticoagulants, which are essential for managing conditions like deep vein thrombosis, pulmonary embolism, and myocardial infarction [5]. Beyond their role in the blood, these binding events also influence cellular signaling, inflammation, and angiogenesis, reflecting the broad biological impact of glycosaminoglycan-protein interactions [6]. However, the non-specific nature of some sulfated polysaccharides can lead to adverse effects, such as heparin-induced thrombocytopenia, necessitating careful monitoring of therapeutic efficacy and safety [7].

Other names

Heparin-binding coagulation factorsSulfated polysaccharide-binding proteinsAntithrombin-binding proteinsGlycosaminoglycan-binding coagulation factorsProcoagulant serine proteases

Sulfated polysaccharides bind to and allosterically activate Antithrombin III and Heparin Cofactor II, which then neutralize procoagulant serine proteases such as Thrombin and Factor Xa [3][4]. They may also act as a bridge to facilitate the interaction between the inhibitor and the enzyme, or bind directly to procoagulant factors to inhibit their assembly into complexes [5].